Physician

Aliya S. Naseer, MD

According to 2025 Medicare claims, Aliya Naseer, MD (NPI: 1568572758) practices endocrinology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is ROCKFORD HEALTH PHYSICIANS (NPI: 1043242886; TIN: 363907436) and primary practice location at 61111-3107. Naseer is affiliated with the Mercy Health Corporation (ACO ID: A2097) and OSF Healthcare System (ACO ID: A3289), participating under the MSSP model.

Naseer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 480 traditional Medicare patients, billed 1,335 HCPCS/CPT codes, and received $61,567 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 8,532 prescription claims across 845 beneficiaries totaling $2,688,420 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 1,267 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $93,347 to $61,567. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,082,549 to $2,688,420. For DME billing, reported payments rose steadily, from $29,995 to $281,470.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	568	7,136	$93,347
2016	545	5,880	$98,113
2017	559	2,994	$99,638
2018	702	6,230	$113,726
2019	731	3,946	$78,027
2020	675	1,337	$48,489
2021	689	1,334	$65,394
2022	539	1,118	$59,960
2023	512	1,063	$60,624
2024	480	1,335	$61,567

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	450	4,989	$1,082,549
2016	469	5,366	$1,183,341
2017	508	5,579	$1,349,746
2018	687	7,315	$2,076,249
2019	681	6,998	$2,106,471
2020	704	6,738	$2,165,275
2021	727	7,244	$2,700,506
2022	739	6,983	$2,761,242
2023	895	7,399	$3,205,794
2024	845	8,532	$2,688,420

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	373	1,007	$47,479
2016	338	974	$44,539
2017	250	687	$42,193
2018	284	848	$59,921
2019	281	924	$117,412
2020	293	1,028	$135,790
2021	289	1,133	$151,900
2022	269	1,090	$150,063
2023	304	1,299	$224,760
2024	328	1,267	$302,231

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	80	95	$95
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	30	30	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	402	633	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	16	16	$37
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	144	249	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	214	7,396	$277,746
Jardiance	Empagliflozin	252	11,647	$226,429
Trulicity	Dulaglutide	175	6,769	$224,999
Ozempic	Semaglutide	170	6,609	$207,408
Farxiga	Dapagliflozin Propanediol	158	7,975	$150,300

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	126	687	$218,933
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	18	83	$20,932
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	26	80	$18,862
E0784	External ambulatory infusion pump, insulin	Y	N/R	54	$18,624
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$9,052

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Aliya S. Naseer, MD?

Tedicare shows public-source Medicare data for Aliya S. Naseer, MD (NPI 1568572758), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aliya S. Naseer, MD have ACO affiliation data?

Aliya S. Naseer, MD is shown with ACO affiliation data for Mercy Health Corporation (MSSP, ACO ID A2097) and OSF Healthcare System (MSSP, ACO ID A3289).

What billing organization is linked to Aliya S. Naseer, MD?

Aliya S. Naseer, MD is linked to ROCKFORD HEALTH PHYSICIANS (billing NPI 1043242886) in the available physician profile data.

Does Aliya S. Naseer, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.